Exposure to PFAS and small for gestational age new-borns: A birth records study in Veneto Region (Italy).


Journal

Environmental research
ISSN: 1096-0953
Titre abrégé: Environ Res
Pays: Netherlands
ID NLM: 0147621

Informations de publication

Date de publication:
05 2020
Historique:
received: 26 11 2019
revised: 05 02 2020
accepted: 19 02 2020
pubmed: 3 3 2020
medline: 11 11 2020
entrez: 3 3 2020
Statut: ppublish

Résumé

Perfluoroalkylated substances (PFAS) in serum are inversely associated with fetal growth. Small for gestational age (SGA) is a measure based on birth weight and gestational age at birth and represents a good indicator of fetal growth but it has been used only in a small number of studies. We examined the association between PFAS exposure and the risk of severe SGA in a PFAS contaminated area in the Veneto Region (North-East of Italy). A retrospective cohort study has been developed including all singleton live births reported in the Veneto Region Birth Registry between 2003 and 2018 to mothers living in the contaminated and in a control area. We estimated the association between mothers' area of residence and severe SGA using crude RR (and 95% CI) and stepwise logistic regression, including all the maternal characteristics. The study included 105,114 singleton live births. The occurence of severe SGA was 3.44% in the contaminated area and 2.67% in the control area. The multivariate analysis confirmed that living in the contaminated area significantly increased the odds of severe SGA (adjusted OR 1.27 (95% C.I. 1.16, 1.39)). The findings suggest that living in a contaminated area by PFAS plays a role in affecting fetal growth and support the hypothesis that PFAS exposure is a risk factor for SGA. Individual data on exposure are needed to confirm the direct association.

Sections du résumé

BACKGROUND
Perfluoroalkylated substances (PFAS) in serum are inversely associated with fetal growth. Small for gestational age (SGA) is a measure based on birth weight and gestational age at birth and represents a good indicator of fetal growth but it has been used only in a small number of studies. We examined the association between PFAS exposure and the risk of severe SGA in a PFAS contaminated area in the Veneto Region (North-East of Italy).
METHODS
A retrospective cohort study has been developed including all singleton live births reported in the Veneto Region Birth Registry between 2003 and 2018 to mothers living in the contaminated and in a control area. We estimated the association between mothers' area of residence and severe SGA using crude RR (and 95% CI) and stepwise logistic regression, including all the maternal characteristics.
RESULTS
The study included 105,114 singleton live births. The occurence of severe SGA was 3.44% in the contaminated area and 2.67% in the control area. The multivariate analysis confirmed that living in the contaminated area significantly increased the odds of severe SGA (adjusted OR 1.27 (95% C.I. 1.16, 1.39)).
CONCLUSIONS
The findings suggest that living in a contaminated area by PFAS plays a role in affecting fetal growth and support the hypothesis that PFAS exposure is a risk factor for SGA. Individual data on exposure are needed to confirm the direct association.

Identifiants

pubmed: 32120121
pii: S0013-9351(20)30175-4
doi: 10.1016/j.envres.2020.109282
pii:
doi:

Substances chimiques

Fluorocarbons 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

109282

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interests The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Silvia Manea (S)

Veneto Region Rare Diseases Coordinating Centre, Veneto Region Birth Register, University Hospital of Padua, Via Pietro Donà 11, 35129, Padova, Italy. Electronic address: silvia.manea@regione.veneto.it.

Laura Salmaso (L)

Veneto Region Rare Diseases Coordinating Centre, Veneto Region Birth Register, University Hospital of Padua, Via Pietro Donà 11, 35129, Padova, Italy.

Giulia Lorenzoni (G)

Veneto Region Rare Diseases Coordinating Centre, Veneto Region Birth Register, University Hospital of Padua, Via Pietro Donà 11, 35129, Padova, Italy.

Monica Mazzucato (M)

Veneto Region Rare Diseases Coordinating Centre, Veneto Region Birth Register, University Hospital of Padua, Via Pietro Donà 11, 35129, Padova, Italy.

Francesca Russo (F)

Directorate of Prevention, Food Safety, and Veterinary Public Health of Veneto Region, Dorsoduro, 3493, Rio Nuovo, 30123, Venezia, Italy.

Domenico Mantoan (D)

Health and Social Care Directorate, Veneto Region, Palazzo Molin, San Polo, 2514, 30125, Venezia, Italy.

Marco Martuzzi (M)

Environment and Health Impact Assessment, WHO European Centre for Environment and Health, Platz der Vereinten Nationen, 1, D-53113, Bonn, Germany.

Tony Fletcher (T)

London School of Hygiene and Tropical Medicine, 15-17, Tavistock Place, WC1H 9SH, London, United Kingdom.

Paola Facchin (P)

Veneto Region Rare Diseases Coordinating Centre, Veneto Region Birth Register, University Hospital of Padua, Via Pietro Donà 11, 35129, Padova, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH